Actively Recruiting
Observational Pediatric Registry for the Acclarent AERA Eustachian Tube Balloon Dilation System Tracking Safety and Effectiveness in Children Under 18
Led by Integra LifeSciences Corporation · Updated on 2026-07-07
300
Participants Needed
9
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect real-world evidence on the continued clinical performance of the AERA device in children with dysfunction of the Eustachian tube. It is a prospective, multi-center, observational registry designed to monitor outcomes in pediatric patients undergoing Eustachian Tube Balloon Dilation ETBD using the AERA device. Participants will be observed following an attempted ETBD procedure using the AERA device. No additional treatments or interventions are assigned by the study. Data collected will include clinical performance and patient outcomes over a period of up to 27 months after the procedure. During the study, participants will undergo assessments such as tympanogram, pure tone audiometry, Valsalva maneuver, inflammation scoring, and patient questionnaires including the Eustachian Tube Dysfunction Questionnaire ETDQ-7 and Otitis Media-6 Questionnaire OM-6. Researchers will monitor the failure-free rate of ETBD with the AERA device and evaluate ear-related function and inflammation. The total participation may last up to 27 months post-procedure to gather comprehensive outcome data.
CONDITIONS
Brief Title
AERA Pediatrics Registry
Research Team
A
Ashley Ellis
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here